ESR1 and breast cancer: Moreover, Petruolo et al. conducted a retrospective analysis of 402 ER+, HER2− breast cancer patients that assessed the rates of pCR and found a significantly lower rate of pCR in PgR-positive patients, which is also consistent with our results [24].